Service de gastro-entérologie

Equipe principale
Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


1629 publications

Sous presse | 2024 | 2023 | 2022 | 2021 | ...
Sous presse
 
Design of a phase 3, randomized, double-blind, placebo-controlled, 48-week study to evaluate the efficacy and safety of cendakimab in adult and adolescent patients with eosinophilic esophagitis.
Charriez C.M., Zhang S., de Oliveira CHMC, Patel V., Oh Y.S., Hirano I., Schoepfer A., Dellon E.S. Contemporary clinical trials. Peer-reviewed.
[DOI][Pmid][serval:BIB_43518F371E90]
 
Endoscopic Ultrasound-Guided Hepaticojejunostomy in Patients with History of total Gastrectomy: a Multicenter Retrospective Feasibility Study.
Daniele B., Jean-Philippe R., Marion S., Sébastien G., Enrique P.C., Solene H., Yanis D., Meddy D., Jean-Baptiste C., Fabrice C. et al. Gastrointestinal endoscopy. Peer-reviewed.
[DOI][Pmid][serval:BIB_E05C6AA23492]
 
Simultaneous combined transplantation: Intricacies in immunosuppression management.
Del Bello A., Vionnet J., Congy-Jolivet N., Kamar N. Transplantation reviews. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_ADE0D933916F]
 
Abdominal surgery in patients with chronic noncirrhotic extrahepatic portal vein obstruction: A multicenter retrospective study.
Elkrief L., Denecheau-Girard C., Magaz M., Praktiknjo M., Colucci N., Ollivier-Hourmand I., Dumortier J., Simon Talero M., Tellez L., Artru F. et al. Hepatology. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0DE823BA59BB]
 
Brief Report: Targeted Therapies and Pancreatitis in Patients With Advanced Nonsmall Cell Lung Cancer.
Meyer M.L., Gros L., Décosterd N., Tagliamento M., Marinello A., Planchard D., Combarel D., Barlesi F., Remon J., Besse B. et al. Clinical lung cancer. Peer-reviewed.
[DOI][Pmid][serval:BIB_F266F0517CF6]
 
An algorithm for the diagnosis and treatment of eosinophilic esophagitis in adults, 2024 update.
Pfefferlé M., Greuter T. Allergy. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7EFA7B2EB5A9]
 
Editorial: To Stop Or Not To Stop: Is It Still A Question?
Vavricka S.R., Greuter T. Alimentary pharmacology & therapeutics. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_AA0FB33B50E6]
 
Fecal urgency and incontinence in inflammatory bowel disease perceived by physician and patient: Results from the Swiss fecal urgency survey.
Wespi N., Vavricka S., Brand S., Aepli P., Burri E., Misselwitz B., Seibold F., Hruz P., Peyrin-Biroulet L., Schoepfer A. et al. United European gastroenterology journal. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3730D295C2F7]
2024
 
HEV ORF2 protein-antibody complex deposits are associated with glomerulonephritis in hepatitis E with reduced immune status.
Leblond A.L., Helmchen B., Ankavay M., Lenggenhager D., Jetzer J., Helmchen F., Yurtsever H., Parrotta R., Healy M.E., Pöschel A. et al., 2024/10/14. Nature communications, 15 (1) p. 8849. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F9027826DDB4]
 
Odynophagia and Retrosternal Pain Are Common in Eosinophilic Esophagitis and Associated with an Increased Overall Symptom Severity.
Karpf J., Safroneeva E., Rossel J.B., Hildenbrand F., Saner C., Greuter T., Rogler G., Straumann A., Schoepfer A., Biedermann L. et al., 2024/10. Digestive diseases and sciences, 69 (10) pp. 3853-3862. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8B1A18F02DAC]
 
A Hepatitis E Virus Infection Model in the Mongolian Gerbil: Ready for Antiviral and Vaccine Studies.
Gouttenoire J., Neyts J., 2024/09. Gastroenterology, 167 (4) pp. 652-653. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_59C46FAACE17]
 
Targeting senescence induced by age or chemotherapy with a polyphenol-rich natural extract improves longevity and healthspan in mice.
Zumerle S., Sarill M., Saponaro M., Colucci M., Contu L., Lazzarini E., Sartori R., Pezzini C., Rinaldi A., Scanu A. et al., 2024/09. Nature aging, 4 (9) pp. 1231-1248. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F01027CE166C]
 
Cancer du pancréas : une épidémie oncologique en devenir ?
Frossard J.L., Moradpour D., 2024/08/28. Revue medicale suisse, 20 (884) pp. 1439-1440. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_C321A58B9B03]
 
Maladie de reflux ­gastro-­œsophagien en 2024 [Gastroesophageal reflux disease in 2024]
Dalex M., Schoepfer A.M., Wakim El-Khoury J., 2024/08/28. Revue medicale suisse, 20 (884) pp. 1464-1468. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_C6AB966A31CF]
 
Maladie hépatique associée à la chirurgie de Fontan [Fontan associated liver disease]
Shams T., Salvador Nunes L., Schmidt S., Gast E., Sempoux C., Moradpour D., Di Bernardo S., Sekarski N., Rutz T., Ladouceur M. et al., 2024/08/28. Revue medicale suisse, 20 (884) pp. 1469-1475. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_DBD6FFB49480]
 
Échoendoscopie thérapeutique : une technique innovante qui révolutionne la pratique [Therapeutic endoscopic ultrasound: an innovative technique, revolutionizing our practice]
Robert-Dubois M., Godat S., Oumrani S., Romailler É., Dalex M., Marx M., 2024/08/28. Revue medicale suisse, 20 (884) pp. 1450-1455. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_E059A3431714]
Trends in the burden of hospitalised patients with cirrhosis in Switzerland: a cross-sectional study of cirrhosis-related hospitalisations between 1998 and 2020.
Favre-Bulle T., Moradpour D., Marques-Vidal P., Vaucher J., 2024/08/24. BMJ open, 14 (8) pp. e081822. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_90F12319EA28]
Direct oral anticoagulants in cirrhosis: Rationale and current evidence.
Pereira Portela C., Gautier L.A., Zermatten M.G., Fraga M., Moradpour D., Bertaggia Calderara D., Aliotta A., Veuthey L., De Gottardi A., Stirnimann G. et al., 2024/08. JHEP reports, 6 (8) p. 101116. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D5D0DE4EEB1E]
High prevalence of short telomeres in idiopathic porto-sinusoidal vascular disorder.
Coukos A., Saglietti C., Sempoux C., Haubitz M., Greuter T., Mittaz-Crettol L., Maurer F., Mdawar-Bailly E., Moradpour D., Alberio L. et al., 2024/08/01. Hepatology communications, 8 (8). Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9145CDB2582B]
 
Effect of Direct Acting Antiviral Drugs on the Occurrence and Recurrence of Intra- and Extra-Hepatic Malignancies in Patients with Chronic Hepatitis C Virus Infection.
Radu P., Becchetti C., Schropp J., Schmid P., Künzler-Heule P., Mertens J., Moradpour D., Müllaupt B., Semela D., Negro F. et al., 2024/07/18. Cancers, 16 (14). Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C2C7FA113E6A]
 
Cancer du côlon chez les 45-49 ans : dépistage systématique ou ciblé ? [Colorectal cancer in 45-49-year-olds: systematic or targeted screening?]
Brändle K., Ducros C., Diserens C., Berger C., Godat S., Bulliard J.L., 2024/07/03. Revue medicale suisse, 20 (881) pp. 1309-1313. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_F41034B86ECC]
 
Eosinophil Distribution in Eosinophilic Esophagitis and its Impact on Disease Activity and Response to Treatment.
Godat A., Mueller R., Schenker D., Schoepfer A.M., Straumann A., Greuter T., EoE Eosinophil Distribution Research Group, 2024/07. Clinical gastroenterology and hepatology, 22 (7) pp. 1528-1530.e3. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D4F03167A7BC]
 
Long-Term Outcome of Surgery for Perianal Crohn's Fistula.
Schaad M., Schoepfer A., Rossel J.B., Barry M.P., Rogler G., Hahnloser D., Swiss IBD Cohort Study Group, 2024/06/24. Medicina, 60 (7). Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_AFD225280E30]
Real-life experience of chronic hepatitis C treatment in Switzerland: a retrospective analysis.
Moschouri E., Salemme G., Baserga A., Cerny A., Deibel A., Müllhaupt B., Meier M.A., Bernsmeier C., Ongaro M., Negro F. et al., 2024/06/24. Swiss medical weekly, 154 (6) p. 3698. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_10FF40A294DD]
Joint host-pathogen genomic analysis identifies hepatitis B virus mutations associated with human NTCP and HLA class I variation.
Xu Z.M., Gnouamozi G.E., Rüeger S., Shea P.R., Buti M., Chan H.L., Marcellin P., Lawless D., Naret O., Zeller M. et al., 2024/06/06. American journal of human genetics, 111 (6) pp. 1018-1034. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9CF13B4886CA]
Novel transcriptomic panel identifies histologically active eosinophilic oesophagitis.
Gueguen E., Morsy Y., Mamie C., Schoepfer A., Saner C., Biedermann L., Straumann A., Kreienbühl A., Swiss EoE Cohort Study Group, Scharl M. et al., 2024/06/06. Gut, 73 (7) pp. 1076-1086. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1A42823616C5]
Inborn errors of type I interferon immunity in patients with symptomatic acute hepatitis E.
Saadat A., Gouttenoire J., Ripellino P., Semela D., Amar S., Frey B.M., Fontana S., Mdawar-Bailly E., Moradpour D., Fellay J. et al., 2024/06/01. Hepatology, 79 (6) pp. 1421-1431. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_212560170173]
Functional results after hiatal repair and gastropexy without fundoplication in patients with paraoesophageal hernia.
Bomio-Pacciorini L., Gaspar-Figueiredo S., Mantziari S., Godat S., Schäfer M., Teixeira Farinha H., 2024/05/03. Langenbeck's archives of surgery, 409 (1) p. 150. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D7D694E97669]
 
Endoscopic Features of Eosinophilic Esophagitis.
Schoepfer A.M., Safroneeva E., Peterson K., 2024/05. Immunology and allergy clinics of North America, 44 (2) pp. 197-204. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_535FE63E288E]
 
Endoscopic Features of Eosinophilic Gastrointestinal Diseases.
Greuter T., Katzka D., 2024/05. Immunology and allergy clinics of North America, 44 (2) pp. 357-368. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F9E6872E5AEC]
 
Surgical site infections after kidney transplantation are independently associated with graft loss.
Schreiber P.W., Hoessly L.D., Boggian K., Neofytos D., van Delden C., Egli A., Dickenmann M., Hirzel C., Manuel O., Koller M. et al., 2024/05. American journal of transplantation, 24 (5) pp. 795-802. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5E28895E3E42]
A Multicenter Long-Term Cohort Study of Eosinophilic Esophagitis Variants and Their Progression to Eosinophilic Esophagitis Over Time.
Greuter T., Straumann A., Fernandez-Marrero Y., Germic N., Hosseini A., Chanwangpong A., Yousefi S., Simon D., Collins M.H., Bussmann C. et al., 2024/04/01. Clinical and translational gastroenterology, 15 (4) pp. e00664. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_B5830A4A0F89]
Influence of Amino Acid Substitutions in Capsid Proteins of Coxsackievirus B5 on Free Chlorine and Thermal Inactivation.
Torii S., Gouttenoire J., Kumar K., Antanasijevic A., Kohn T., 2024/03/26. Environmental science & technology, 58 (12) pp. 5279-5289. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1DCF2058B13C]
EUS-BD for calibration of benign stenosis of the bile duct in patients with altered anatomy or inaccessible papilla.
Caillol F., Godat S., Solovyev A., Harouchi A., Oumrani S., Marx M., Hoibian S., Dahel Y., Ratone J.P., Giovannini M., 2024/03. Endoscopy international open, 12 (3) pp. E377-E384. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E356174D051A]
Immune Monitoring-Guided Versus Fixed Duration of Antiviral Prophylaxis Against Cytomegalovirus in Solid-Organ Transplant Recipients: A Multicenter, Randomized Clinical Trial.
Manuel O., Laager M., Hirzel C., Neofytos D., Walti L.N., Hoenger G., Binet I., Schnyder A., Stampf S., Koller M. et al., 2024/02/17. Clinical infectious diseases, 78 (2) pp. 312-323. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_AA450EA2BB8A]
 
ECCO Guidelines on Extraintestinal Manifestations in Inflammatory Bowel Disease.
Gordon H., Burisch J., Ellul P., Karmiris K., Katsanos K., Allocca M., Bamias G., Barreiro-de Acosta M., Braithwaite T., Greuter T. et al., 2024/01/27. Journal of Crohn's & colitis, 18 (1) pp. 1-37. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4B7885474F8D]
 
Gastroentérologie et hépatologie: ce qui a changé en 2023 [Gastroenterology and hepatology: what's new in 2023]
Fraga M., Wakim El-Khoury J., Oumrani S., Godat S., Vionnet J., Schoepfer A., Vieira Barbosa J., 2024/01/17. Revue medicale suisse, 20 (856-7) pp. 42-46. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_7B220EB3FD8F]
A false positive hair ethylglucuronide dosage in an alcohol abstinent patient after liver transplantation: a case report.
Favrod-Coune T., Lidsky D., Vionnet J., Magini G., Déglon J., Broers B., 2024. Frontiers in medicine, 11 p. 1363012. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_14DB621B2EC1]
 
Ascending to New Heights for Novel Therapeutics for Eosinophilic Esophagitis.
Hirano I., Dellon E.S., Falk G.W., Gonsalves N.P., Furuta G.T., Bredenoord A.J., ASCENT WORKING GROUP, 2024/01. Gastroenterology, 166 (1) pp. 1-10. Peer-reviewed.
[DOI][Pmid][serval:BIB_02F6F3512140]
Cohort Profile Update: The Swiss Eosinophilic Esophagitis Cohort Study (SEECS).
El-Khoury J.W., Safroneeva E., Saner C., Rossel J.B., Trelle S., Zwahlen M., Biedermann L., Kreienbuehl A., Greuter T., Schreiner P. et al., 2024. Inflammatory intestinal diseases, 9 (1) pp. 165-173. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_D83422944708]
Frequency and impact on renal transplant outcomes of urinary tract infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species.
Brune J.E., Dickenmann M., Sidler D., Walti L.N., Golshayan D., Manuel O., Haidar F., Neofytos D., Schnyder A., Boggian K. et al., 2024. Frontiers in medicine, 11 p. 1329778. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E14F344895B2]
 
Histological Phenotyping in Eosinophilic Esophagitis: Localized Proximal Disease Is Infrequent but Associated with Less Severe Disease and Better Disease Outcome.
Heil A., Kuehlewindt T., Godat A., Simon H.U., Simon D., Schreiner P., Saner C., Vavricka S.R., Biedermann L., Safroneeva E. et al., 2024. International archives of allergy and immunology, 185 (1) pp. 63-72. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E37AA02D6B02]
 
Intestinal Ultrasonography Diagnostic Performance and Feasibility in IBD during Pregnancy: A Systematic Review and Narrative Synthesis.
Pillet J., Voirol-Perrin J., Martel M., Kherad O., Restellini S., 2024. Inflammatory intestinal diseases, 9 (1) pp. 229-240. Peer-reviewed.
[DOI][Pmid][serval:BIB_82BAD220A85B]
 
Pediatric Patients with Eosinophilic Esophagitis and Their Parents Identify Symptoms as the Most Important Treatment Outcome.
von Graffenried T., Safroneeva E., Braegger C., Ezri J., Garzoni L., Giroud Rivier A., Greuter T., Köhler H., McLin V.A., Marx G. et al., 2024. International archives of allergy and immunology, 185 (6) pp. 527-535. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4D63EADCDE35]
 
Pharmacologic Treatment of Eosinophilic Esophagitis: Efficacious, Likely Efficacious, and Failed Drugs.
Schoepfer A.M., Safroneeva E., 2024. Inflammatory intestinal diseases, 9 (1) pp. 199-209. Peer-reviewed.
[DOI][Pmid][serval:BIB_BFBE92233B29]
The Genetics of Inflammatory Bowel Disease.
El Hadad J., Schreiner P., Vavricka S.R., Greuter T., 2024/01. Molecular diagnosis & therapy, 28 (1) pp. 27-35. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CE26F5D1F449]
 
Time since liver transplant and immunosuppression withdrawal outcomes: Systematic review and individual patient data meta-analysis.
Appenzeller-Herzog C., Rosat A., Mathes T., Baroja-Mazo A., Chruscinski A., Feng S., Herrero I., Londono M.C., Mazariegos G., Ohe H. et al., 2024/01. Liver international, 44 (1) pp. 250-262. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3830325733B5]
2023
 
A genome-wide CRISPR/Cas9 screen identifies a role for Rab5A and early endosomes in hepatitis E virus replication.
Oechslin N., Da Silva N., Ankavay M., Moradpour D., Gouttenoire J., 2023/12/26. Proceedings of the National Academy of Sciences of the United States of America, 120 (52) pp. e2307423120. Peer-reviewed.
[DOI][Pmid][serval:BIB_804B2FF5304B]
 
[Eosinophilic oesophagitis and eosinophilic gastrointestinal diseases].
Waldegg C., Greuter T., 2023/12. Therapeutische Umschau. Revue therapeutique, 79 (9) pp. 423-428. Peer-reviewed.
[Pmid][serval:BIB_1635B5F802C7]
 
Antithrombotic therapy and assessment for bleeding diathesis in elective gastrointestinal endoscopy - Expert Opinion Statement on behalf of the Swiss Society of Gastroenterology.
Wiegand N., Geyer M., Lollo G., Wuillemin W.A., Aepli P., Frei R., Godat S., Manz M., Seewald S., The F.O. et al., 2023/12. Praxis, 112 (13) pp. 635-641. Peer-reviewed.
[Pmid][serval:BIB_1EC6C7D4840F]
Endoscopic ultrasound-guided modification of surgical anatomy (from Roux-en-Y gastrectomy to Billroth II-like anatomy) for endoscopic treatment of malignant biliary stenosis.
Piazza G., Lázaro-Fontanet E., Cotton A., Godat S., Galasso D., 2023/12. Endoscopy, 55 (S 01) pp. E827-E828. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2778B1837378]
 
Toward antivirals against hepatitis E: In the steps of hepatitis C.
Gouttenoire J., Neyts J., 2023/12/01. Hepatology, 78 (6) pp. 1695-1697. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0E75926FCAEF]
 
An Unusual Cause of Severe Granulomatous Hepatitis and Jaundice.
Coukos A., Uldry E., Meylan S., Schmidt S., Fasquelle F., Sempoux C., Fraga M., 2023/11/01. The American journal of gastroenterology, 118 (11) p. 1920. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E1B8A245AB14]
Antibody Response After the Third SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients and People Living With HIV (COVERALL-2).
Griessbach A., Chammartin F., Abela I.A., Amico P., Stoeckle M.P., Eichenberger A.L., Hasse B., Braun D.L., Schuurmans M.M., Müller T.F. et al., 2023/11. Open forum infectious diseases, 10 (11) pp. ofad536. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_AA0E2350DF22]
Relaxation of the lower esophageal sphincter in response to reduced volume distension during FLIP Panometry.
Wakim El-Khoury J., Pandolfino J.E., Kahrilas P.J., Godo B., Farina D.A., Kou W., Carlson D.A., 2023/11. Neurogastroenterology and motility, 35 (11) pp. e14663. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_5201F8954956]
Splanchnic vein thrombosis associated with SARS-CoV-2 infection: A VALDIG case-control study.
Deltenre P., Payancé A., Elkrief L., Mura V., Artru F., Baiges A., Cervoni J.P., China L., Colle I., Lemaitre E. et al., 2023/11. JHEP reports, 5 (11) p. 100894. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_82E56B86E53E]
 
Endoscopic Ultrasound-guided Radiofrequency Ablation Versus Surgical Resection for Treatment of Pancreatic Insulinoma.
Crinò S.F., Napoleon B., Facciorusso A., Lakhtakia S., Borbath I., Caillol F., Do-Cong Pham K., Rizzatti G., Forti E., Palazzo L. et al., 2023/10. Clinical gastroenterology and hepatology, 21 (11) pp. 2834-2843.e2. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A0A2001C18D6]
 
Radiofrequency Ablation of Pancreatic Solid Tumors.
Giovannini M., Marx M., 2023/10. Gastrointestinal endoscopy clinics of North America, 33 (4) pp. 855-865. Peer-reviewed.
[DOI][Pmid][serval:BIB_F189D2444213]
 
The combination of non-contrast abbreviated MRI and alpha foetoprotein has high performance for hepatocellular carcinoma screening.
Girardet R., Dubois M., Manasseh G., Jreige M., Du Pasquier C., Canniff E., Gulizia M., Bonvin M., Aleman Y., Taouli B. et al., 2023/10. European radiology, 33 (10) pp. 6929-6938. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E8467CFFB8EE]
International survey among hepatologists and pulmonologists on the hepatic hydrothorax: plea for recommendations.
Cadranel J.D., Ollivier-Hourmand I., Cadranel J., Thevenot T., Zougmore H., Nguyen-Khac E., Bureau C., Allaire M., Nousbaum J.B., Loustaud-Ratti V. et al., 2023/09/12. BMC gastroenterology, 23 (1) p. 305. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1C2271EE16DF]
Elevated liver function tests in a patient with breast cancer.
Neftel C., Zaman K., Chtioui H., Moradpour D., Sempoux C., Fraga M., 2023/09. Journal of hepatology, 79 (3) pp. e109-e111. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E70D878557D9]
 
Monitoring Patients With Eosinophilic Esophagitis in Routine Clinical Practice - International Expert Recommendations.
Arnim U.V., Biedermann L., Aceves S.S., Bonis P.A., Collins M.H., Dellon E.S., Furuta G.T., Gonsalves N., Gupta S., Hirano I. et al., 2023/09. Clinical gastroenterology and hepatology, 21 (10) pp. 2526-2533. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F47BC34D3614]
 
Dyspepsie fonctionnelle : update 2023 [Functional dyspepsia : update 2023]
Voirol-Perrin J., Stamm G.M., Salvador Nunes L., Schoepfer A., 2023/08/30. Revue medicale suisse, 19 (839) pp. 1554-1557. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_B38DE2D08B8C]
 
Hépatologie en 2023 : importance de la multidisciplinarité.
Fraga M., Spahr L., 2023/08/30. Revue medicale suisse, 19 (839) pp. 1535-1536. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_7ED0D526DAE8]
 
Prise en charge de la dysphagie [Management of dysphagia]
Caloz E., Tripet R., Marx M., Oumrani S., Ghaoui C., Wakim El-Khoury J., Godat S., Robert M., 2023/08/30. Revue medicale suisse, 19 (839) pp. 1548-1553. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_046383CA7597]
 
Traitements à siRNA : état des lieux et perspectives [siRNA therapeutics : Current options and perspectives]
Neftel C., Moradpour D., 2023/08/30. Revue medicale suisse, 19 (839) pp. 1538-1542. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_42C4E3231286]
Swiss expert opinion: current approaches in faecal microbiota transplantation in daily practice.
Rossier L., Matter C., Burri E., Galperine T., Hrúz P., Juillerat P., Schoepfer A., Vavricka S.R., Zahnd N., Décosterd N. et al., 2023/08/25. Swiss medical weekly, 153 p. 40100. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0CA45BC676CD]
Body composition and short-term mortality in patients critically ill with acute-on-chronic liver failure.
Mangana Del Rio T., Sacleux S.C., Vionnet J., Ichaï P., Denys A., Schneider A., Coilly A., Fraga M., Wetzel A., Koerfer J. et al., 2023/08. JHEP reports, 5 (8) p. 100758. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4CE069EB4A31]
 
ECCO Guidelines on Inflammatory Bowel Disease and Malignancies.
Gordon H., Biancone L., Fiorino G., Katsanos K.H., Kopylov U., Al Sulais E., Axelrad J.E., Balendran K., Burisch J., de Ridder L. et al., 2023/06/16. Journal of Crohn's & colitis, 17 (6) pp. 827-854. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C14EBA0E24E7]
 
Prise en charge de la cholécystite aiguë [Management of acute cholecystitis]
Rrupa D., Robert-Dubois M., Uldry E., Demartines N., Halkic N., Godat S., Melloul E., 2023/06/14. Revue medicale suisse, 19 (831) pp. 1175-1179. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_8A5B380F58EE]
The current and future burden of hepatitis B in Switzerland: a modelling study.
Negro F., Müllhaupt B., Semela D., Blach S., Bruggmann P., De Gottardi A., Dufour J.F., Fraga M., Galante A., Razavi H. et al., 2023/06/05. Swiss medical weekly, 153 p. 40086. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0D701EB32CF2]
Bacteremia During the First Year After Solid Organ Transplantation: An Epidemiological Update.
Neofytos D., Stampf S., Hoessly L.D., D'Asaro M., Tang G.N., Boggian K., Hirzel C., Khanna N., Manuel O., Mueller N.J. et al., 2023/06. Open forum infectious diseases, 10 (6) pp. ofad247. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_93C3850C4E55]
 
Barrett's Esophagus in Eosinophilic Esophagitis in Swiss Eosinophilic Esophagitis Cohort Study (SEECS).
Scherer R., Schreiner P., Rossel J.B., Greuter T., Burri E., Saner C., Schlag C., Safroneeva E., Schoepfer A., Straumann A. et al., 2023/05. Digestive diseases, 41 (5) pp. 695-707. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_40DC7A3B7D2A]
 
Letter to the editor: discussing the place of TIPS in noncirrhotic patients with chronic extrahepatic portal vein occlusion (EHPVO).
Artru F., Rautou P.E., Denys A., 2023/05/01. Hepatology, 77 (5) pp. E91-E92. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A9D7911B251B]
 
Novel targets in EoE: one step forward?
Straumann A., Greuter T., 2023/05. Gut, 72 (5) pp. 811-812. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2BF5747716ED]
 
Urine: a place where HEV cannot hide!
Behrendt P., Gouttenoire J., 2023/05/01. Hepatology, 77 (5) pp. 1475-1477. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0981E87E5B52]
Vaccine-Preventable Infections Among Solid Organ Transplant Recipients in Switzerland.
Walti L.N., Mugglin C., Mombelli M., Manuel O., Hirsch H.H., Khanna N., Mueller N.J., Berger C., Boggian K., Garzoni C. et al., 2023/04/03. JAMA network open, 6 (4) pp. e2310687. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8F026B83CBA0]
Antibody Response After Third Vaccination With mRNA-1273 or BNT162b2: Extension of a Randomized Controlled SARS-CoV-2 Noninferiority Vaccine Trial in Patients With Different Levels of Immunosuppression (COVERALL-2).
Griessbach A., Chammartin F., Abela I.A., Amico P., Stoeckle M.P., Eichenberger A.L., Hasse B., Braun D.L., Schuurmans M.M., Müller T.F. et al., 2023/04. Open forum infectious diseases, 10 (4) pp. ofad150. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_EA3FA50DC390]
 
Efficacy and safety of endoscopic ultrasound guided drainage of pseudocysts and walled-off necrosis after failure of percutaneous drainage.
Mack S., Galasso D., Marx M., Robert M., Romailler E., Oumrani S.H., Aslan N., Moschouri E., Schoepfer A., Godat S., 2023/04. Surgical endoscopy, 37 (4) pp. 2626-2632. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0250829E9F69]
Häufige Magen-Darm-Beschwerden: Management der funktionellen Dyspepsie und des Reizdarm-Syndroms in der Praxis [Frequent Gastro-Intestinal Disorders: Management of Functional Dyspepsia and Irritable Bowel Syndrome in Clinical Practice]
Pohl D., Vavricka S., Fox M., Madisch A., Studerus D., Wiesel P., Heinrich H., Linas I., Schoepfer A., Schwizer A. et al., 2023/04. Praxis, 112 (5-6) pp. 304-316. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_EC5B4C8E20D3]
Expanding the Hepatitis E Virus Toolbox: Selectable Replicons and Recombinant Reporter Genomes.
Oechslin N., Ankavay M., Moradpour D., Gouttenoire J., 2023/03/28. Viruses, 15 (4) p. 869. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D5D9E0EC07AC]
 
Dupilumab in Patients with Eosinophilic Esophagitis.
Greuter T., Schoepfer A.M., 2023/03/09. The New England journal of medicine, 388 (10) pp. 955-956. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_39F5B2710C23]
Clinical prediction model for prognosis in kidney transplant recipients (KIDMO): study protocol.
Schwab S., Sidler D., Haidar F., Kuhn C., Schaub S., Koller M., Mellac K., Stürzinger U., Tischhauser B., Binet I. et al., 2023/03/07. Diagnostic and prognostic research, 7 (1) p. 6. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_69CC7CCAA980]
External validation and comparison of the Glasgow-Blatchford score, modified Glasgow-Blatchford score, Rockall score and AIMS65 score in patients with upper gastrointestinal bleeding: a cross-sectional observational study in Western Switzerland.
Rivieri S., Carron P.N., Schoepfer A., Ageron F.X., 2023/02/01. European journal of emergency medicine, 30 (1) pp. 32-39. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1AB5646B3D5A]
Gastroentérologie et hépatologie : ce qui a changé en 2022 [Gastroenterology and hepatology: what's new in 2022]
Fraga M., Ghaoui C., Stamm G.M., Schoepfer A., Greuter T., 2023/02/01. Revue medicale suisse, 19 (812) pp. 217-220. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_43ED67B9D44E]
Genetic variation in TERT modifies the risk of hepatocellular carcinoma in alcohol-related cirrhosis: results from a genome-wide case-control study.
Buch S., Innes H., Lutz P.L., Nischalke H.D., Marquardt J.U., Fischer J., Weiss K.H., Rosendahl J., Marot A., Krawczyk M. et al., 2023/02. Gut, 72 (2) pp. 381-391. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2B792B958267]
 
Noncirrhotic Portal Vein Cavernous Transformation: To TIPS, or Not to TIPS, That Is the Question.
Denys A., Artru F., 2023/02. Journal of vascular and interventional radiology, 34 (2) pp. 195-196. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_06F2CA32F795]
Preoperative hiatal hernia in esophageal adenocarcinoma; does it have an impact on patient outcomes?
St-Amour P., Mantziari S., Dromain C., Winiker M., Godat S., Schoepfer A., Demartines N., Schäfer M., 2023/02. Surgical oncology, 46 p. 101904. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A823709CEFB9]
Response to a letter to the editor: a better understanding of Immune Checkpoint Inhibitor-induced cholangitis for better management.
Coukos A., Vionnet J., Sempoux C., Fraga M., 2023/02. Journal for immunotherapy of cancer, 11 (2) pp. e006877. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0C82ABD0A663]
Alcohol and cannabis consumption in patients with inflammatory bowel disease: prevalence, pattern of consumption and impact on the disease.
Martinho-Grueber M., Kapoglou I., Bravo F., Sarraj R., Benz E., Restellini S., Biedermann L., Rogler G., Vavricka S.R., Schoepfer A. et al., 2023/01/01. European journal of gastroenterology & hepatology, 35 (1) pp. 21-30. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1B0BE72B83BD]
Donation type and the effect of pre-transplant donor specific antibodies - Data from the Swiss Transplant Cohort Study.
de Rougemont O., Deng Y., Frischknecht L., Wehmeier C., Villard J., Ferrari-Lacraz S., Golshayan D., Gannagé M., Binet I., Wirthmueller U. et al., 2023. Frontiers in immunology, 14 p. 1104371. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9C3FDBD902B3]
Eosinophilic Esophagitis beyond Eosinophils - an Emerging Phenomenon Overlapping with Eosinophilic Esophagitis: Collegium Internationale Allergologicum (CIA) Update 2023.
Salvador Nunes V.S., Straumann A., Salvador Nunes L., Schoepfer A.M., Greuter T., 2023. International archives of allergy and immunology, 184 (5) pp. 411-420. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8B8C8631DBBF]
Immunohistochemistry for hepatitis E virus capsid protein cross-reacts with cytomegalovirus-infected cells: a potential diagnostic pitfall.
Lenggenhager D., Grossmann J., Gouttenoire J., Sempoux C., Weber A., 2023/01. Histopathology, 82 (2) pp. 354-358. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_27C183206471]
Marked weight loss on liraglutide 3.0 mg: Real-life experience of a Swiss cohort with obesity.
Santini S., Vionnet N., Pasquier J., Gonzalez-Rodriguez E., Fraga M., Pitteloud N., Favre L., 2023/01. Obesity, 31 (1) pp. 74-82. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4496D948ED59]
Outcome of nonfunctioning pancreatic neuroendocrine tumors after initial surveillance or surgical resection: a single-center observational study.
Marx M., Caillol F., Godat S., Poizat F., Oumrani S., Ratone J.P., Hoibian S., Dahel Y., Oziel-Taieb S., Niccoli P. et al., 2023. Annals of gastroenterology, 36 (6) pp. 686-693. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_FA0C0B1BEDFB]
2022
The endocytic recycling compartment serves as a viral factory for hepatitis E virus.
Bentaleb C., Hervouet K., Montpellier C., Camuzet C., Ferrié M., Burlaud-Gaillard J., Bressanelli S., Metzger K., Werkmeister E., Ankavay M. et al., 2022/12/03. Cellular and molecular life sciences, 79 (12) p. 615. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_AEFE49C06E94]
 
A homemade endoscopic guillotine strikes again: removal of a nasogastric tube mysteriously knotted in the proximal third of the esophagus.
Pinto do Couto F., Cavin A., Pittet O., Archanioti P., Godat S., Galasso D., 2022/12. Endoscopy, 54 (12) pp. E676-E677. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DC51E284DDD8]
Drug-Related Adverse Events Necessitating Treatment Discontinuation in Pediatric Inflammatory Bowel Disease Patients.
Salzmann M., von Graffenried T., Righini-Grunder F., Braegger C., Spalinger J., Schibli S., Schoepfer A., Nydegger A., Pittet V., Sokollik C. et al., 2022/12/01. Journal of pediatric gastroenterology and nutrition, 75 (6) pp. 731-736. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_58679FB6964E]
Epidemiology and outcomes of bone and joint infections in solid organ transplant recipients.
Pham T.T., Andrey D.O., Stampf S., Burkhard S.H., Hirzel C., Tschopp J., Ullrich K., Strahm C., Schreiber P.W., Boillat-Blanco N. et al., 2022/12. American journal of transplantation, 22 (12) pp. 3031-3046. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_FE1913230C55]
 
Rectal organoid-guided CFTR modulator therapy restores lung function in a cystic fibrosis patient with the rare 1677delTA/R334W genotype.
Mitropoulou G., Brandenberg N., Hoehnel S., Ceroni C., Balmpouzis Z., Blanchon S., Dorta G., Sauty A., Koutsokera A., 2022/12. The European respiratory journal, 60 (6) p. 2201341. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DA1096E6DF8A]
 
Diagnostic Delay in Patients With Eosinophilic Esophagitis Has Not Changed Since the First Description 30 Years Ago: Diagnostic Delay in Eosinophilic Esophagitis.
Murray F.R., Kreienbuehl A.S., Greuter T., Nennstiel S., Safroneeva E., Saner C., Schindler V., Schlag C., Schoepfer A.M., Schreiner P. et al., 2022/11/01. The American journal of gastroenterology, 117 (11) pp. 1772-1779. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6CCB7290833F]
Fluticasone Propionate Orally Disintegrating Tablet (APT-1011) for Eosinophilic Esophagitis: Randomized Controlled Trial.
Dellon E.S., Lucendo A.J., Schlag C., Schoepfer A.M., Falk G.W., Eagle G., Nezamis J., Comer G.M., Knoop K., Hirano I., 2022/11. Clinical gastroenterology and hepatology, 20 (11) pp. 2485-2494.e15. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_DE556B826D15]
 
International Consensus Recommendations for Eosinophilic Gastrointestinal Disease Nomenclature.
Dellon E.S., Gonsalves N., Abonia J.P., Alexander J.A., Arva N.C., Atkins D., Attwood S.E., Auth MKH, Bailey D.D., Biederman L. et al., 2022/11. Clinical gastroenterology and hepatology, 20 (11) pp. 2474-2484.e3. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_EA0E64471012]
The personality traits activity, self-reproach, and negative affect jointly predict clinical recurrence, depressive symptoms, and low quality of life in inflammatory bowel disease patients.
Jordi SBU, Lang B.M., Wyss J., Auschra B., Yilmaz B., Krupka N., Greuter T., Schreiner P., Biedermann L., Preisig M. et al., 2022/11. Journal of gastroenterology, 57 (11) pp. 848-866. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F1C754D68334]
Efficacy of Intravenous Ustekinumab Reinduction in Patients With Crohn's Disease With a Loss of Response.
Heron V., Li Fraine S., Panaccione N., Restellini S., Germain P., Candido K., Bernstein C.N., Bessissow T., Bitton A., Chauhan U.K. et al., 2022/10. Journal of the Canadian Association of Gastroenterology, 5 (5) pp. 208-213. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_1FC60D4520F6]
 
Endoscopic approach to eosinophilic esophagitis: American Society for Gastrointestinal Endoscopy Consensus Conference.
Aceves S.S., Alexander J.A., Baron T.H., Bredenoord A.J., Day L., Dellon E.S., Falk G.W., Furuta G.T., Gonsalves N., Hirano I. et al., 2022/10. Gastrointestinal endoscopy, 96 (4) pp. 576-592.e1. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6030963F350C]
Systematic comparison with autoimmune liver disease identifies specific histological features of immune checkpoint inhibitor-related adverse events.
Coukos A., Vionnet J., Obeid M., Bouchaab H., Peters S., Latifyan S., Wicky A., Michielin O., Chtioui H., Moradpour D. et al., 2022/10. Journal for immunotherapy of cancer, 10 (10) pp. e005635. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F836C2B098EA]
Use of statins after liver transplantation is associated with improved survival: results of a nationwide study.
Becchetti C., Dirchwolf M., Schropp J., Magini G., Müllhaupt B., Immer F., Dufour J.F., Banz V., Berzigotti A., Bosch J. et al., 2022/10. Alimentary pharmacology & therapeutics, 56 (7) pp. 1194-1204. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9E54BA86BE04]
 
Management of eosinophilic esophagitis associated food impaction in Europe and the United States.
Schreiner P., Safroneeva E., Schoepfer A., Greuter T., Biedermann L., Schlag C., Labenz J., Auth MKH, Bredenoord A.J., Chang J.W. et al., 2022/09/14. Diseases of the esophagus, 35 (9) pp. doac003. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_22D1BE680162]
 
EUS-guided hepaticogastrostomy in the management of malignant biliary obstruction: Experience and learning curve in a tertiary referral center.
Marx M., Caillol F., Sfumato P., Romero J., Ratone J.P., Pesenti C., Godat S., Hoibian S., Dahel Y., Boher J.M. et al., 2022/09. Digestive and liver disease, 54 (9) pp. 1236-1242. Peer-reviewed.
[DOI][Pmid][serval:BIB_BF5C987A0E57]
 
Hepatitis B reactivation during ruxolitinib treatment.
Sjoblom M., Chtioui H., Fraga M., Stalder G., Grandoni F., Blum S., 2022/09. Annals of hematology, 101 (9) pp. 2081-2086. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_97208521780E]
 
Management of non-functional pancreatic neuroendocrine tumors by endoscopic ultrasound-guided radiofrequency ablation: Retrospective study in two tertiary centers.
Marx M., Godat S., Caillol F., Poizat F., Ratone J.P., Pesenti C., Schoepfer A., Hoibian S., Dahel Y., Giovannini M., 2022/09. Digestive endoscopy, 34 (6) pp. 1207-1213. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_41768A5E0562]
 
Mechanotransduction-induced glycolysis epigenetically regulates a CXCL1-dominant angiocrine signaling program in liver sinusoidal endothelial cells in vitro and in vivo.
Greuter T., Yaqoob U., Gan C., Jalan-Sakrikar N., Kostallari E., Lu J., Gao J., Sun L., Liu M., Sehrawat T.S. et al., 2022/09. Journal of hepatology, 77 (3) pp. 723-734. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A4EDE98D5887]
 
Reply to the letter to the editor.
Caillol F., Godat S., Giovannini M., 2022/09. Digestive endoscopy, 34 (6) p. 1258. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2FB4E32D6C1B]
Diagnostic différentiel et investigation de la diarrhée chronique [Differential diagnosis and investigation of chronic diarrhea]
Stamm G.M., Salvador Nunes L., Greuter T., Godat S., Schoepfer A., 2022/08/31. Revue medicale suisse, 18 (793) pp. 1578-1583. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_67B37C79B9F9]
La résection endoscopique va-t-elle suppléer la chirugie ?
Frossard J.L., Moradpour D., 2022/08/31. Revue medicale suisse, 18 (793) pp. 1575-1576. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_51AC5AB4D8B3]
Métabolisme et suivi thérapeutique de l’azathioprine en gastroentérologie et hépatologie [Metabolism and therapeutic monitoring of azathioprine in gastroenterology and hepatology]
Bianchetti D., Salvador Nunes L., André P., Schoepfer A., Moradpour D., Chtioui H., 2022/08/31. Revue medicale suisse, 18 (793) pp. 1588-1593. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_8BF7916B0E8B]
Syndrome des télomères courts chez l’adulte : une entité rare qu’il faut savoir évoquer [Short telomere syndrome in adults: a rare entity that should be evoked]
Coukos A., Daccord C., Lazor R., Blum S., Naveiras O., Unger S., Vionnet J., Gaide O., Koutsokera A., Moschouri E. et al., 2022/08/31. Revue medicale suisse, 18 (793) pp. 1606-1613. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_610156412D48]
Antibody Response in Immunocompromised Patients After the Administration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine BNT162b2 or mRNA-1273: A Randomized Controlled Trial.
Speich B., Chammartin F., Abela I.A., Amico P., Stoeckle M.P., Eichenberger A.L., Hasse B., Braun D.L., Schuurmans M.M., Müller T.F. et al., 2022/08/24. Clinical infectious diseases, 75 (1) pp. e585-e593. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_B952B5300090]
An Arginine-Rich Motif in the ORF2 capsid protein regulates the hepatitis E virus lifecycle and interactions with the host cell.
Hervouet K., Ferrié M., Ankavay M., Montpellier C., Camuzet C., Alexandre V., Dembélé A., Lecoeur C., Foe A.T., Bouquet P. et al., 2022/08. PLoS pathogens, 18 (8) pp. e1010798. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F4C125B10C4D]
Characterization of eosinophilic esophagitis variants by clinical, histological, and molecular analyses: A cross-sectional multi-center study.
Greuter T., Straumann A., Fernandez-Marrero Y., Germic N., Hosseini A., Yousefi S., Simon D., Collins M.H., Bussmann C., Chehade M. et al., 2022/08. Allergy, 77 (8) pp. 2520-2533. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_EAD7D6441714]
Disease Burden and Unmet Need in Eosinophilic Esophagitis.
Bredenoord A.J., Patel K., Schoepfer A.M., Dellon E.S., Chehade M., Aceves S.S., Spergel J.M., Shumel B., Deniz Y., Rowe P.J. et al., 2022/08/01. The American journal of gastroenterology, 117 (8) pp. 1231-1241. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CAD58AB5D2A0]
Portal vein recanalisation alone to treat severe portal hypertension in non-cirrhotic patients with chronic extrahepatic portal vein obstruction.
Artru F., Vietti-Violi N., Sempoux C., Vieira Barbosa J., Becce F., Sah N., Marot A., Deltenre P., Moschouri E., Fraga M. et al., 2022/08. JHEP reports, 4 (8) p. 100511. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7BEB3C21A016]
 
Sex Impacts Disease Activity But Not Symptoms or Quality of Life in Adults With Eosinophilic Esophagitis.
Schreiner P., Safroneeva E., Rossel J.B., Limacher A., Saner C., Greuter T., Schoepfer A., Straumann A., Biedermann L., 2022/08. Clinical gastroenterology and hepatology, 20 (8) pp. 1729-1738.e1. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_11C6E0A0F532]
Developing and testing a Corona VaccinE tRiAL pLatform (COVERALL) to study Covid-19 vaccine response in immunocompromised patients.
Kusejko K., Chammartin F., Smith D., Odermatt M., Schuhmacher J., Koller M., Günthard H.F., Briel M., Bucher H.C., Speich B. et al., 2022/07/28. BMC infectious diseases, 22 (1) p. 654. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_66CD4B7631A4]
 
A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions.
Dellon E.S., Khoury P., Muir A.B., Liacouras C.A., Safroneeva E., Atkins D., Collins M.H., Gonsalves N., Falk G.W., Spergel J.M. et al., 2022/07. Gastroenterology, 163 (1) pp. 59-76. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_57554F3F7CF5]
 
A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions.
Dellon E.S., Khoury P., Muir A.B., Liacouras C.A., Safroneeva E., Atkins D., Collins M.H., Gonsalves N., Falk G.W., Spergel J.M. et al., 2022/07. The Journal of allergy and clinical immunology, 150 (1) pp. 33-47. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_83643E8C3009]
Impact of Diagnostic Delay on Disease Course in Pediatric- versus Adult-Onset Patients with Ulcerative Colitis: Data from the Swiss IBD Cohort.
Schoepfer A.M., Tran VDC, Rossel J.B., Sokollik C., Spalinger J., Safroneeva E., von Graffenried T., Godat S., Hahnloser D., Vavricka S.R. et al., 2022/07. Inflammatory intestinal diseases, 7 (2) pp. 87-96. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_0F43F897750F]
 
The MELD upgrade exception: a successful strategy to optimize access to liver transplantation for patients with high waiting list mortality.
Dirchwolf M., Becchetti C., Gschwend S.G., Toso C., Dutkowski P., Immer F., Beyeler F., Rossi S., Schropp J., Dufour J.F. et al., 2022/07. HPB, 24 (7) pp. 1168-1176. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_63DBC81F8439]
Therapy Patterns and Surveillance Measures of Inflammatory Bowel Disease Patients beyond Disease-Related Hospitalization: A Claims-Based Cohort Study.
Bähler C., Brüngger B., Blozik E., Vavricka S.R., Schoepfer A.M., 2022/07. Inflammatory intestinal diseases, 7 (2) pp. 104-117. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_B7C916D780E9]
 
EUS-guided radiofrequency ablation for pancreatic insulinoma: experience in 2 tertiary centers.
Marx M., Trosic-Ivanisevic T., Caillol F., Demartines N., Schoepfer A., Pesenti C., Ratone J.P., Robert M., Giovannini M., Godat S., 2022/06. Gastrointestinal endoscopy, 95 (6) pp. 1256-1263. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C40F3E310F5D]
 
Reliability and responsiveness of endoscopic disease activity assessment in eosinophilic esophagitis.
Ma C., Bredenoord A.J., Dellon E.S., Alexander J.A., Biedermann L., Hogan M., Guizzetti L., Zou G., Katzka D.A., Chehade M. et al., 2022/06. Gastrointestinal endoscopy, 95 (6) pp. 1126-1137.e2. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6917DB7B01C7]
Méthodes diagnostiques non invasives de l'Helicobacter pylori
Raiss Rida, Koehli Lionel, Schoepfer Alain, Gouveia Alexandre, 2022/05/10. Forum Médical Suisse ‒ Swiss Medical Forum, 22 (1920). Peer-reviewed.
[URN][DOI][serval:BIB_E44DE0443149]
Impact of Overweight and Obesity on Disease Outcome in the Pediatric Swiss Inflammatory Bowel Disease Cohort.
von Graffenried T., Schoepfer A.M., Rossel J.B., Greuter T., Safroneeva E., Godat S., Henchoz S., Vavricka S.R., Sokollik C., Spalinger J. et al., 2022/05. JPGN reports, 3 (2) pp. e193. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_317305A3A540]
 
Prevention of viral infections in solid organ transplant recipients in the era of COVID-19: a narrative review.
Filippidis P., Vionnet J., Manuel O., Mombelli M., 2022/05. Expert review of anti-infective therapy, 20 (5) pp. 663-680. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_EBA61FD0AC5F]
The rs429358 Locus in Apolipoprotein E Is Associated With Hepatocellular Carcinoma in Patients With Cirrhosis.
Innes H., Nischalke H.D., Guha I.N., Weiss K.H., Irving W., Gotthardt D., Barnes E., Fischer J., Ansari M.A., Rosendahl J. et al., 2022/05. Hepatology communications, 6 (5) pp. 1213-1226. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_FF7D93901041]
 
A Natural Polyphenol Exerts Antitumor Activity and Circumvents Anti-PD-1 Resistance through Effects on the Gut Microbiota.
Messaoudene M., Pidgeon R., Richard C., Ponce M., Diop K., Benlaifaoui M., Nolin-Lapalme A., Cauchois F., Malo J., Belkaid W. et al., 2022/04/01. Cancer discovery, 12 (4) pp. 1070-1087. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_20DD01671E5B]
Budesonide orodispersible tablets for induction of remission in patients with active eosinophilic oesophagitis: A 6-week open-label trial of the EOS-2 Programme.
Miehlke S., Schlag C., Lucendo A.J., Biedermann L., Vaquero C.S., Schmoecker C., Hayat J., Hruz P., Ciriza de Los Rios C., Bredenoord A.J. et al., 2022/04. United European gastroenterology journal, 10 (3) pp. 330-343. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_07838D1B3DDB]
Close follow-up is associated with fewer stricture formation and results in earlier detection of histological relapse in the long-term management of eosinophilic esophagitis.
Bon L., Safroneeva E., Bussmann C., Biedermann L., Schreiner P., Vavricka S.R., Schoepfer A.M., McCright-Gill T., Simon H.U., Straumann A. et al., 2022/04. United European gastroenterology journal, 10 (3) pp. 308-318. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_930966748188]
Direct intrahepatic portocaval shunt (DIPS) or transjugular transcaval intrahepatic portosystemic shunt (TTIPS) to treat complications of portal hypertension: Indications, technique, and outcomes beyond Budd-Chiari syndrome.
Artru F., Moschouri E., Denys A., 2022/04. Clinics and research in hepatology and gastroenterology, 46 (4) p. 101858. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4BDBDC78FFD7]
Fibrosis-4 Index as an Independent Predictor of Mortality and Liver-Related Outcomes in NAFLD.
Vieira Barbosa J., Milligan S., Frick A., Broestl J., Younossi Z., Afdhal N.H., Lai M., 2022/04. Hepatology communications, 6 (4) pp. 765-779. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_656541921C65]
GM-CSF is key in the efficacy of vaccine-induced reduction of Helicobacter pylori infection.
Vaillant L., Oster P., McMillan B., Orozco Fernandez E., Velin D., 2022/04. Helicobacter, 27 (2) pp. e12875. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E9724186F668]
High-dimensional immune phenotyping of blood cells by mass cytometry in patients infected with hepatitis C virus.
Herderschee J., Heinonen T., Fenwick C., Schrijver I.T., Ohmiti K., Moradpour D., Cavassini M., Pantaleo G., Roger T., Calandra T. et al., 2022/04. Clinical microbiology and infection, 28 (4) pp. 611.e1-611.e7. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_300AF1BADC64]
 
Humoral response to SARS-CoV-2 infection among liver transplant recipients.
Becchetti C., Broekhoven AGC, Dahlqvist G., Fraga M., Zambelli M.F., Ciccarelli O., Saouli A.C., Trizzino A., Banz V., Dufour J.F. et al., 2022/04. Gut, 71 (4) pp. 746-756. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8FC720DDECC5]
Lipoprotein Z, a hepatotoxic lipoprotein, predicts outcome in alcohol-associated hepatitis.
Hu K., Perez-Matos M.C., Argemi J., Vilar-Gomez E., Shalaurova I., Bullitt E., Landeen L., Sugahara G., Deng H., Mathur K. et al., 2022/04. Hepatology, 75 (4) pp. 968-982. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_821F00F0B361]
 
Long-Lasting Dissociation of Esophageal Eosinophilia and Symptoms After Dilation in Adults With Eosinophilic Esophagitis.
Safroneeva E., Pan Z., King E., Martin L.J., Collins M.H., Yang G.Y., Capocelli K.E., Arva N.C., Abonia J.P., Atkins D. et al., 2022/04. Clinical gastroenterology and hepatology, 20 (4) pp. 766-775.e4. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_BC3C6855ACB8]
 
Fibrosis-4 Index Can Independently Predict Major Adverse Cardiovascular Events in Nonalcoholic Fatty Liver Disease.
Vieira Barbosa J., Milligan S., Frick A., Broestl J., Younossi Z., Afdhal N., Lai M., 2022/03/01. The American journal of gastroenterology, 117 (3) pp. 453-461. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C4EB459F1069]
 
Helicobacter pylori infection has a detrimental impact on the efficacy of cancer immunotherapies.
Oster P., Vaillant L., Riva E., McMillan B., Begka C., Truntzer C., Richard C., Leblond M.M., Messaoudene M., Machremi E. et al., 2022/03. Gut, 71 (3) pp. 457-466. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_142E8F1FCE05]
Increasing prevalence of obesity and diabetes among patients evaluated for liver transplantation in a Swiss tertiary referral center: a 10-year retrospective analysis.
Kasmi S., Artru F., Barbosa J.V., Deibel A.R., Favre L., Peuble C., Saouli A.C., Goossens N., Müllhaupt B., Pascual M. et al., 2022/02/28. Swiss medical weekly, 152 pp. w30138. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_14011818DC4B]
Development of a core outcome set for therapeutic studies in eosinophilic esophagitis (COREOS).
COREOS Collaborators:, Ma C., Schoepfer A.M., Dellon E.S., Bredenoord A.J., Chehade M., Collins M.H., Feagan B.G., Furuta G.T., Gupta S.K. et al., 2022/02. The Journal of allergy and clinical immunology, 149 (2) pp. 659-670. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F00CA8B7F661]
 
Primary Hypogammaglobulinaemia with Inflammatory Bowel Disease-Like Features: An ECCO CONFER Multicentre Case Series.
Albshesh A., Eder P., Ribaldone D.G., Oldenburg B., de Boer N.K., Mantzaris G.J., Savarino E.V., Dragoni G., Weisshof R., Truyens M. et al., 2022/01/28. Journal of Crohn's & colitis, 16 (1) pp. 91-97. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F864C66DDE01]
A Response to: Letter to the Editor Regarding 'Iron Formulations for the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease: A Cost-Effectiveness Analysis in Switzerland'.
Aksan A., Schoepfer A., Juillerat P., Vavricka S., Bettencourt M., Ramirez de Arellano A., Gavata S., Morin N., Valentine W.J., Hunt B., 2022/01. Advances in therapy, 39 (1) pp. 815-821. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A40FF400F640]
 
Biomarkers of Operational Tolerance After Liver Transplantation: Are We There Yet?
Vionnet J., Sánchez-Fueyo A., 2022/01. Liver transplantation, 28 (1) pp. 15-16. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3095F073B49C]
Effect of closed and permanent stoma on disease course, psychological well-being and working capacity in Swiss IBD cohort study patients.
Bianchi R., Mamadou-Pathé B., von Känel R., Roth R., Schreiner P., Rossel J.B., Burk S., Dora B., Kloth P., Rickenbacher A. et al., 2022. PloS one, 17 (9) pp. e0274665. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7EE1550BAF4D]
Effectiveness of golimumab in patients with ulcerative colitis: results of a real-life study in Switzerland.
Perrig K., Krupka N., Jordi SBU, Rossel J.B., Biedermann L., Greuter T., Schreiner P., Vavricka S.R., Juillerat P., Burri E. et al., 2022. Therapeutic advances in gastroenterology, 15 p. 17562848221074188. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_B459DBE19976]
Helicobacter pylori serology is associated with worse overall survival in patients with melanoma treated with immune checkpoint inhibitors.
Tonneau M., Nolin-Lapalme A., Kazandjian S., Auclin E., Panasci J., Benlaifaoui M., Ponce M., Al-Saleh A., Belkaid W., Naimi S. et al., 2022. Oncoimmunology, 11 (1) p. 2096535. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D970B474B020]
Hepatitis E virus RNA-dependent RNA polymerase is involved in RNA replication and infectious particle production.
Oechslin N., Da Silva N., Szkolnicka D., Cantrelle F.X., Hanoulle X., Moradpour D., Gouttenoire J., 2022/01. Hepatology, 75 (1) pp. 170-181. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_17749E50F16F]
Iberogast®-Induced Acute Liver Injury-A Case Report.
Leroy A., Perrin H., Porret R., Sempoux C., Chtioui H., Fraga M., Bart P.A., 2022. Gastro hep advances, 1 (4) pp. 601-603. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_5E2F0FB82317]
Partial lipodystrophy, severe dyslipidaemia and insulin resistant diabetes as early signs of Werner syndrome.
Atallah I., McCormick D., Good J.M., Barigou M., Fraga M., Sempoux C., Superti-Furga A., Semple R.K., Tran C., 2022. Journal of clinical lipidology, 16 (5) pp. 583-590. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E5FCC361A247]
Positioning biologics in the treatment of IBD: A practical guide - Which mechanism of action for whom?
Juillerat P., Grueber M.M., Ruetsch R., Santi G., Vuillèmoz M., Michetti P., 2022. Current research in pharmacology and drug discovery, 3 p. 100104. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_37C45F4E9C6B]
Strategies for a two-step liver fibrosis assessment in clinical practice.
Vieira Barbosa J., Lai M., 2022/01. JHEP reports, 4 (1) p. 100382. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_249FCA6D8E7D]
The Efficacy of Cancer Immunotherapies Is Compromised by Helicobacter pylori Infection.
Oster P., Vaillant L., McMillan B., Velin D., 2022. Frontiers in immunology, 13 p. 899161. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A0B0F20EDD09]
Transhepatic tract hemostasis using thermal-ablation after percutaneous portal vein access.
Vermersch M., Denys A., Artru F., Tsoumakidou G., Villard N., Duran R., Hocquelet A., 2022/01/01. BJR case reports, 8 (1) p. 20210080. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_974485F89B91]
2021
 
Effectiveness and Safety of High- vs Low-Dose Swallowed Topical Steroids for Maintenance Treatment of Eosinophilic Esophagitis: A Multicenter Observational Study.
Greuter T., Godat A., Ringel A., Almonte H.S., Schupack D., Mendoza G., McCright-Gill T., Dellon E.S., Hirano I., Alexander J. et al., 2021/12. Clinical gastroenterology and hepatology, 19 (12) pp. 2514-2523.e2. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_99DEF5677C2D]
 
Large-scale screening is not useful for identifying individuals with hepatitis B or C virus infection: A prospective Swiss study.
Djebali-Trabelsi A., Marot A., André C., Deltenre P., 2021/12. Journal of viral hepatitis, 28 (12) pp. 1756-1758. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_894D4FE26DFE]
 
Non-invasive alloimmune risk stratification of long-term liver transplant recipients.
Vionnet J., Miquel R., Abraldes J.G., Wall J., Kodela E., Lozano J.J., Ruiz P., Navasa M., Marshall A., Nevens F. et al., 2021/12. Journal of hepatology, 75 (6) pp. 1409-1419. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C066065054FC]
Acute Lower Gastrointestinal Bleeding in an Emergency Department and Performance of the SHA<sub>2</sub>PE Score: A Retrospective Observational Study.
Cerruti T., Maillard M.H., Hugli O., 2021/11/23. Journal of clinical medicine, 10 (23) p. 5476. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1A28C0872140]
 
Technical feasibility, clinical effectiveness, and safety of esophageal stricture dilation using a novel endoscopic attachment cap in adults with eosinophilic esophagitis.
Schoepfer A.M., Henchoz S., Biedermann L., Schreiner P., Greuter T., Reinhard A., Senn J., Franke A., Burri E., Juillerat P. et al., 2021/11. Gastrointestinal endoscopy, 94 (5) pp. 912-919.e2. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_593B5147966C]
 
Clinical parameters and biomarkers predicting spontaneous operational tolerance after liver transplantation: A scoping review.
Appenzeller-Herzog C., Hartleif S., Vionnet J., 2021/10. American journal of transplantation, 21 (10) pp. 3312-3323. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1ECF701F3E52]
Increasing Incidence of Microscopic Colitis in a Population-Based Cohort Study in Switzerland.
Maye H., Safroneeva E., Godat S., Sempoux C., Yan P., Bouzourène H., Seelentag W., Stauffer E., Taminelli L., Seibold F. et al., 2021/10. Clinical gastroenterology and hepatology, 19 (10) pp. 2205-2206. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_493358506C2A]
 
Higher educational level in patients with eosinophilic esophagitis: a comparative analysis.
Roth R., Safroneeva E., Saner Zilian C., Schreiner P., Rossel J.B., Bopp M., Greuter T., Scharl M., Pittet V., Rogler G. et al., 2021/09/09. Diseases of the esophagus, 34 (9) pp. doab010. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B37A9AB205C3]
 
A Summary of the Meetings of the Development of a Core Outcome Set for Therapeutic Studies in Eosinophilic Esophagitis (COREOS) International Multidisciplinary Consensus.
Ma C., Schoepfer A.M., Safroneeva E., COREOS Collaborators, 2021/09. Gastroenterology, 161 (3) pp. 778-784. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_380CDA43B2B6]
Actualités en endoscopie digestive : trois procédures endoscopiques prometteuses [Novelties in digestive endoscopy: three promising endoscopic procedures]
Gfeller É., Romailler É., Ollo D., Robert M., Greuter T., Schoepfer A., Godat S., 2021/09/01. Revue medicale suisse, 17 (748) pp. 1443-1447. Peer-reviewed.
[URN][Pmid][serval:BIB_9FDA21581618]
 
Clinicopathologic Correlations in Eosinophilic Gastrointestinal Disorders.
Pesek R.D., Greuter T., Lopez-Nunez O., Bernieh A., Straumann A., Collins M.H., 2021/09. The journal of allergy and clinical immunology. In practice, 9 (9) pp. 3258-3266. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_412ACBF5BF84]
 
Development of a Core Outcome Set for Therapeutic Studies in Eosinophilic Esophagitis (COREOS): An International Multidisciplinary Consensus.
Ma C., Schoepfer A.M., Safroneeva E., COREOS Collaborators, COREOS Collaborators, 2021/09. Gastroenterology, 161 (3) pp. 748-755. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_41C7983BC020]
 
Emerging Therapies for Eosinophilic Gastrointestinal Diseases.
Peterson K., Safroneeva E., Schoepfer A., 2021/09. The journal of allergy and clinical immunology. In practice, 9 (9) pp. 3276-3281. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CDF975F1E049]
 
Gastrointestinal quality of life before and short- and long-term after Roux-en-Y gastric bypass for severe obesity.
Waridel C., Schoepfer A., Suter M., 2021/09. Surgery for obesity and related diseases, 17 (9) pp. 1583-1590. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_EEB870AFF361]
Guide pratique de la prise en charge des patients avec maladies inflammatoires chroniques de l’intestin pour les médecins généralistes [A practical guide to chronic inflammatory bowel disease]
Salvador Nunes L., Greuter T., Henchoz S., Schoepfer A., 2021/09/01. Revue medicale suisse, 17 (748) pp. 1448-1452. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_CD66190C9E74]
 
High levels of interleukine-6 in ascites prevent ascites reinfusion during hemodialysis.
Halfon M., Artru F., Fraga M., Comte D., Alberio L., Brunet J.F., Fakhouri F., Kissling S., 2021/09. Clinics and research in hepatology and gastroenterology, 45 (5) p. 101734. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_286BB643A89B]
Hépatite autoimmune : mise au point 2021 [Autoimmune hepatitis: 2021 update]
Stamm G.M., Sempoux C., Fraga M., Comte D., Aubert V., Moradpour D., Vionnet J., Moschouri E., 2021/09/01. Revue medicale suisse, 17 (748) pp. 1457-1463. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_E7CF6654AD62]
Impact du Covid-19 sur la gastroentérologie et l’hépatologie.
Schoepfer A., Frossard J.L., MORADPOUR D., 2021/09/01. Revue medicale suisse, 17 (748) p. 1435. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_2C233243DC6D]
The impact of colectomy on the course of extraintestinal manifestations in Swiss inflammatory bowel disease cohort study patients.
Roth R., Vavricka S., Scharl M., Schreiner P., Safroneeva E., Greuter T., Zeitz J., Misselwitz B., Schoepfer A., Barry M.P. et al., 2021/09. United European gastroenterology journal, 9 (7) pp. 773-780. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_3C93EE7DC523]
Correction to: Comparison between microcatheter and nebulizer for generating Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC).
Toussaint L., Sautkin Y., Illing B., Weinreich F.J., Nadiradze G., Königsrainer A., Wichmann D., 2021/08. Surgical endoscopy, 35 (8) p. 4901. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1B46AD84DF68]
 
Resident Kupffer cells and neutrophils drive liver toxicity in cancer immunotherapy.
Siwicki M., Gort-Freitas N.A., Messemaker M., Bill R., Gungabeesoon J., Engblom C., Zilionis R., Garris C., Gerhard G.M., Kohl A. et al., 2021/07/02. Science immunology, 6 (61) pp. eabi7083. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A24074C576A9]
 
DIPS, a safe and effective alternative in patients with unfavorable anatomy to TIPSS: first experience in a tertiary center.
Moschouri E., Hocquelet A., Vermersch M., Fraga M., Denys A., Artru F., 2021/07. Clinics and research in hepatology and gastroenterology, 45 (4) p. 101715. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3B35877741D5]
FOXC2 controls adult lymphatic endothelial specialization, function, and gut lymphatic barrier preventing multiorgan failure.
González-Loyola A., Bovay E., Kim J., Lozano T.W., Sabine A., Renevey F., Arroz-Madeira S., Rapin A., Wypych T.P., Rota G. et al., 2021/07. Science advances, 7 (29) pp. eabf4335. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_3852082D8787]
 
Type D personality is associated with depressive symptoms and clinical activity in inflammatory bowel disease.
Jordi SBU, Botte F., Lang B.M., Greuter T., Krupka N., Auschra B., Schreiner P., Sulz M.C., Biedermann L., von Känel R. et al., 2021/07. Alimentary pharmacology & therapeutics, 54 (1) pp. 53-67. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_458485CA16A8]
 
ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease.
Kucharzik T., Ellul P., Greuter T., Rahier J.F., Verstockt B., Abreu C., Albuquerque A., Allocca M., Esteve M., Farraye F.A. et al., 2021/06/22. Journal of Crohn's & colitis, 15 (6) pp. 879-913. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8AC8F8AD94F3]
 
Gastric eosinophils are detrimental for Helicobacter pylori vaccine efficacy.
Vaillant L., Oster P., McMillan B., Velin D., 2021/06/16. Vaccine, 39 (27) pp. 3590-3601. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_369D55787F13]
Crohn's versus Cancer: Comparison of Functional and Surgical Outcomes after Right-Sided Resections.
Grass F., Zhu E., Brunel C., Hübner M., Schoepfer A., Demartines N., Hahnloser D., 2021/06. Digestive diseases, 39 (2) pp. 106-112. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0561EB080BB1]
Eosinophilic esophagitis-established facts and new horizons.
Biedermann L., Straumann A., Greuter T., Schreiner P., 2021/06. Seminars in immunopathology, 43 (3) pp. 319-335. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A056AB0D59F7]
Radiographic Hepatic Steatosis Is Not Associated With Key Clinical Outcomes Among Patients Hospitalized With COVID-19.
Trivedi H.D., Wilechansky R., Goyes D., Vieira Barbosa J., Canakis A., Lai M., Long M.T., Fricker Z., 2021/06. Gastroenterology research, 14 (3) pp. 179-183. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_17D1D94C33C4]
Long-term outcome of surgery for perianal Crohn's fistula
Schaad M, Hahnloser D, Schoepfer A, Rossel J -B, Rogler G, 2021/05/28. dans Abstracts of the 108th Annual Swiss Congress of Surgery, British Journal of Surgery. Peer-reviewed.
[URN][DOI][WoS][serval:BIB_6B1B657F2F0B]
 
Amino acids in acute-on-chronic liver failure: Another piece of the puzzle?
Coenraad M.J., Artru F., 2021/05. Journal of hepatology, 74 (5) pp. 1015-1017. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F1BA83A75A47]
Autochthonous hepatitis E as a cause of acute-on-chronic liver failure and death: histopathology can be misleading but transaminases may provide a clue.
Vieira Barbosa J., Müllhaupt B., Brunner F., Filipowicz Sinnreich M., Semela D., Montani M., Cathomas G., Neuweiler J., Gouttenoire J., Artru F. et al., 2021/04/26. Swiss medical weekly, 151 pp. w20502. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_EFAEB50E7F8A]
Transplantation de microbiote fécal : de l’évidence aux réalités du terrain [Fecal microbiota transplantation: from the evidence to the realty of the field]
Ballif A., Gerber S., Carrez L., Audry M., Sadeghipour F., Mitouassiwou A., Croxatto A., Opota O., Prod'hom G., Henchoz S. et al., 2021/04/14. Revue medicale suisse, 17 (734) pp. 726-731. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_6F57B9B68184]
 
Emerging treatment options for extraintestinal manifestations in IBD.
Greuter T., Rieder F., Kucharzik T., Peyrin-Biroulet L., Schoepfer A.M., Rubin D.T., Vavricka S.R., 2021/04. Gut, 70 (4) pp. 796-802. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C239C65AF8F0]
Factors influencing the outcome of vedolizumab treatment: Real-life data with objective outcome measurements.
Mader O., Juillerat P., Biedermann L., Michetti P., Hruz P., Pittet V., Rogler G., Zahnd-Straumann N., Seibold F., 2021/04. United European gastroenterology journal, 9 (3) pp. 398-406. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A908FC317058]
 
Recommandations pour le suivi des patients atteints d'hépatite C guérie
Bobzin Carina, Bsiger Christophe, Bruggmann Philip, Cerny Andreas, Fraga Christinet Montserrat, Keiser Olivia, Knzler-Heule Patrizia, Lavanchy Daniel, Maeschli Bettina, Moradpour Darius et al., 2021/03/16. Forum Médical Suisse ‒ Swiss Medical Forum.
[DOI][serval:BIB_402D0B6700D4]
 
Letter: the improvement of sarcopenia after TIPSS might result from the survivor bias-authors' reply.
Artru F., Labreuche J., Duhamel A., Louvet A., 2021/03. Alimentary pharmacology & therapeutics, 53 (5) pp. 677-678. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B1EFC749B2F3]
Long-term Efficacy and Tolerability of RPC4046 in an Open-Label Extension Trial of Patients With Eosinophilic Esophagitis.
Dellon E.S., Collins M.H., Rothenberg M.E., Assouline-Dayan Y., Evans L., Gupta S., Schoepfer A., Straumann A., Safroneeva E., Rodriguez C. et al., 2021/03. Clinical gastroenterology and hepatology, 19 (3) pp. 473-483.e17. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_700A233C12FC]
 
Adherence to Recommendations and Quality of Endoscopic Colorectal Cancer Surveillance in Long-Standing Ulcerative Colitis.
Santi G., Michetti P., Froehlich F., Rossel J.B., Pittet V., Maillard M.H., 2021/02. Inflammatory intestinal diseases, 6 (1) pp. 25-31. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FBFF6A87B0DF]
Nonalcoholic Fatty Liver Disease Screening in Type 2 Diabetes Mellitus Patients in the Primary Care Setting.
Vieira Barbosa J., Lai M., 2021/02. Hepatology communications, 5 (2) pp. 158-167. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_796D315C4310]
Gastroentérologie et hépatologie [Advances in gastroenterology and hepatology 2020]
Artru F., Fraga M., Godat S., Schoepfer A.M., Moradpour D., 2021/01/13. Revue medicale suisse, 17 (720-1) pp. 29-32. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_535230AAAD19]
Hépatite E: Utilité de la sérologie et de la PCR pour le diagnostic
Psychia Eleni, Fraga Christinet Monserrat, Gouveia Alexandre, 2021/01/05. Forum Médical Suisse ‒ Swiss Medical Forum, 21 (01-02) pp. 22-25.
[URN][DOI][serval:BIB_26D6BAE03D0B]
 
Autoimmune hepatitis as a sequelae of oxcarbazepine-induced drug reaction with eosinophilia and systemic symptoms.
Droz N., Chevrier F., Lapointe A.K., Sempoux C., Fraga M., Comte D., 2021/01. The journal of allergy and clinical immunology. In practice, 9 (1) pp. 580-581. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3F757D73A9EF]
 
Benefit of radiofrequency ablation after widespread endoscopic resection of neoplastic Barrett's esophagus in daily practice
Godat Sébastien, 2021. Annals of Gastroenterology.
[DOI][WoS][Pmid][serval:BIB_BAB154E0523E]
Case Report: SARS-CoV-2 as an unexpected causal agent of predominant febrile hepatitis.
Filippidis P., van Ouwenaller F., Cerutti A., Geiger-Jacquod A., Sempoux C., Pantaleo G., Moradpour D., Lamoth F., 2021. F1000Research, 10 p. 400. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_0194C4870252]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University